Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation
- PMID: 20018889
- PMCID: PMC2825401
- DOI: 10.1074/jbc.M109.069542
Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation
Abstract
Soluble amyloid oligomers are potent neurotoxins that are involved in a wide range of human degenerative diseases, including Alzheimer disease. In Alzheimer disease, amyloid beta (Abeta) oligomers bind to neuronal synapses, inhibit long term potentiation, and induce cell death. Recent evidence indicates that several immunologically distinct structural variants exist as follows: prefibrillar oligomers (PFOs), fibrillar oligomers (FOs), and annular protofibrils. Despite widespread interest, amyloid oligomers are poorly characterized in terms of structural differences and pathological significance. FOs are immunologically related to fibrils because they react with OC, a conformation-dependent, fibril-specific antibody and do not react with antibodies specific for other types of oligomers. However, fibrillar oligomers are much smaller than fibrils. FOs are soluble at 100,000 x g, rich in beta-sheet structures, but yet bind weakly to thioflavin T. EPR spectroscopy indicates that FOs display significantly more spin-spin interaction at multiple labeled sites than PFOs and are more structurally similar to fibrils. Atomic force microscopy indicates that FOs are approximately one-half to one-third the height of mature fibrils. We found that Abeta FOs do not seed the formation of thioflavin T-positive fibrils from Abeta monomers but instead seed the formation of FOs from Abeta monomers that are positive for the OC anti-fibril antibody. These results indicate that the lattice of FOs is distinct from the fibril lattice even though the polypeptide chains are organized in an immunologically identical conformation. The FOs resulting from seeded reactions have the same dimensions and morphology as the initial seeds, suggesting that the seeds replicate by growing to a limiting size and then splitting, indicating that their lattice is less stable than fibrils. We suggest that FOs may represent small pieces of single fibril protofilament and that the addition of monomers to the ends of FOs is kinetically more favorable than the assembly of the oligomers into fibrils via sheet stacking interaction. These studies provide novel structural insight into the relationship between fibrils and FOs and suggest that the increased toxicity of FOs may be due to their ability to replicate and the exposure of hydrophobic sheet surfaces that are otherwise obscured by sheet-sheet interactions between protofilaments in a fibril.
Figures
Similar articles
-
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.Mol Neurodegener. 2007 Sep 26;2:18. doi: 10.1186/1750-1326-2-18. Mol Neurodegener. 2007. PMID: 17897471 Free PMC article.
-
Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.PLoS One. 2013 Jul 31;8(7):e70521. doi: 10.1371/journal.pone.0070521. Print 2013. PLoS One. 2013. PMID: 23936224 Free PMC article.
-
Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.J Biol Chem. 2012 Jul 13;287(29):24765-73. doi: 10.1074/jbc.M111.329763. Epub 2012 Apr 30. J Biol Chem. 2012. PMID: 22547072 Free PMC article.
-
New Mechanism of Amyloid Fibril Formation.Curr Protein Pept Sci. 2019;20(6):630-640. doi: 10.2174/1389203720666190125160937. Curr Protein Pept Sci. 2019. PMID: 30686252 Review.
-
Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.Acc Chem Res. 2018 Mar 20;51(3):706-718. doi: 10.1021/acs.accounts.7b00554. Epub 2018 Mar 6. Acc Chem Res. 2018. PMID: 29508987 Free PMC article. Review.
Cited by
-
Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9734-9. doi: 10.1073/pnas.1505420112. Epub 2015 Jul 21. Proc Natl Acad Sci U S A. 2015. PMID: 26199414 Free PMC article.
-
Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells.Korean J Chem Eng. 2012 Jun;29(6):693-702. doi: 10.1007/s11814-012-0060-x. Korean J Chem Eng. 2012. PMID: 23565019 Free PMC article.
-
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.Neurol Neuroimmunol Neuroinflamm. 2016 May 10;3(3):e237. doi: 10.1212/NXI.0000000000000237. eCollection 2016 Jun. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27218118 Free PMC article.
-
In silico cross seeding of Aβ and amylin fibril-like oligomers.ACS Chem Neurosci. 2013 Nov 20;4(11):1488-500. doi: 10.1021/cn400141x. Epub 2013 Sep 19. ACS Chem Neurosci. 2013. PMID: 24007594 Free PMC article.
-
Atomic view of a toxic amyloid small oligomer.Science. 2012 Mar 9;335(6073):1228-31. doi: 10.1126/science.1213151. Science. 2012. PMID: 22403391 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
